Corporate
Symposium
Thalassemia: the
Continued Challenge
Nathan DG
Deferasirox (ICL670):
from bench to bedside
Alberti D
ICL670: clinical
outcome
Cappellini MD
Treatment of aggressive
lymphoma
Gisselbrecht C, Mounier N
Gemtuzumab
ozogamicin
Amadori S
Imatinib – an
overview
Deininger MWN
SKI-606 and
Beyond
Boschelli DH, Boschelli F, Wu B, Ye F, Wang Y, Golas JM, Young T,
Lucas J
Follicular
Lymphomas
Solal-Celigny P
Anti-CD80 Monoclonal
Antibody: Galiximab
Czuczman MS
CD30: a suitable target
for immunotherapy?
Borchmann P
Palifermin
(Kepivance™) in the treatment of mucositis
Emmanouilides C
Combinations of
Biological Agents in Non-Hodgkin’s Lymphomas
Cheson BD
Chronic lymphocytic
leukemia
Gentile M, Guarini A, Mauro FR, Foà R
Bcr-abl peptides for
chronic myeloid leukemia
Bocchia M, Ippoliti M, Pirrotta MT, Abruzzese E, Trawinska MM,
Forconi F, Gozzetti A, Raspadori D, Lauria F
Tumor idyotipe as target
antigen for multiple myeloma
Curti A
Augmenting anti-tumor
efficacy of adoptive immunotherapy with Marrow Infiltrating
Lymphocytes
Borrello I
Bortezomib therapy for
Refractory/Relapsed Multiple Myeloma
Cavo M
Ubiquitin-proteasome
system is a sensitive target in ph+ leukemia
Martinelli G, Cilloni D, Rosti G, Piccaluga P, Rondoni M, Bosi C,
Paolini S, Pane F, Soverini S, Amabile M, Nadali G, Izzo B,
Iacobucci I, Poerio S, Terragna C, Ottaviani E,
Grafone T, De Vivo A, Testoni N, Saglio G, Baccarani M
Bortezomib in
lymphoma
Goy A
Beyond bortezomib alone:
Combination therapy and new strategies in targeting the
proteasome
Richardson PG
Thalidomide
analogs
Tosi P, Zamagni E , Cangini D, Tacchetti P, Perrone G, Ceccolini M,
Cavo M
Tipifarnib in
hematological malignancies
Harousseau J-L
Direct and indirect
antitumor activity of zoledronic acid
Massaia M, Mariani S , Pantaleoni F, Muraro M, Peola S, Hwang SY,
Castella B, Matta G, Foglietta M, Fiore F, Coscia M, Boccadoro M
MLN518 – an
overview
Deininger MWN
Activity of the histone
deacetylase inhibitors LBH589 and LAQ824 in hematologic
malignancies
Bhalla K
Anti-Tumor Activity of
CCI-779 in Relapsed Mantle Cell Lymphoma
Ansell SM, Geyer SM, Kurtin PJ, Rowland KM, Flynn PJ, Morton RF,
Dakhil SR, Gross HM, Maurer MJ, Kaufmann SH, Witzig TE
Gemcitabine: from solid
tumor to hematology
Zinzani PL, Tani M, Stefoni V , Marchi E, Fina M, Alinari L
The Developing Role of
Clofarabine in Acute Leukemias
Faderl S
Oral
fludarabine
Verhoef GEG
Oxaliplatin in
lymphoma
Haioun C, Mondor CH
Lymphomatous
meningitis
Hatton C